Riskpilot← Back to searchSign inGet full accessBØLER LEGESENTER AS
ASActiveOrg 924329459Utmarkveien 1, 0691 OsloGeneral medical practice activities · NACE 8621Est. 20205 employees
Revenue 2024
NOK 3M
+20% vs 2023
EBITDA margin
0.3%
+112% vs 2023
Equity ratio
-8.0%
Financial strength
Net profit 2024
NOK -22K
+76% vs 2023
| Revenue | NOK 3M | +20% |
| EBITDA | NOK 8K | +112% |
| Net profit | NOK -22K | +76% |
| Total assets | NOK 644K | +3% |
| Equity | NOK -51K | -75% |
| Employees | 5 | — |
Legal name
BØLER LEGESENTER AS
Org number
924329459
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
2. januar 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Kontorfellesskap for samarbeidende leger ved bøler legesenter.
Address
Utmarkveien 1, 0691 Oslo
Phone
+4722757100
Email
kontakt@legesenter.org
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 416 | 2 670 | 2 904 | 2 460 | 2 952 |
| Staff expenses | −642 | −721 | −1 163 | −956 | −1 069 |
| EBITDA | 26 | 91 | 44 | −71 | 8 |
| Depreciation & amort. | −23 | −41 | −45 | −19 | −36 |
| EBIT | 3 | 50 | −0 | −90 | −27 |
| Net financials | 0 | 0 | 1 | −0 | 5 |
| Profit before tax | 3 | 50 | 0 | −90 | −22 |
| Tax | −0 | 9 | 3 | −0 | −0 |
| Net profit | 3 | 41 | −2 | −90 | −22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 538 | 810 | 696 | 628 | 644 |
| Equity | 23 | 63 | 61 | −29 | −51 |
| Long-term debt | 398 | 400 | 272 | 427 | 410 |
| Short-term debt | 117 | 347 | 363 | 230 | 285 |
| Total debt | 515 | 747 | 635 | 657 | 695 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20202024
Equity ratio
-8.0%
This company
38.2%
Market median
-121% vs market
20202024
Return on equity
-2199900.0%
This company
18.4%
Market median
-11956078% vs market
20202024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20202024
Asset turnover
4.58×
This company
1.12×
Market median
+309% vs market
20202024
Debt / equity
13.53×
This company
0.62×
Market median
-2082% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NT Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
PW Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.33% | 33.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BØLER LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pernille Willersrud | Chief Executive Officer | 0 companies |
| Nabil Tareq Saleem | Chief Executive Officer | 0 companies |
| Sunder Sharma | Board of Directors | 0 companies |
| Hans Anders Bernhard Hedlin | Chairman | 0 companies |
| Andrey Ilichev | Chairman | 0 companies |